Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C20H29NO3.ClH |
| Molecular Weight | 367.91 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN1CCC[C@H](C1)OC(=O)C(O)(C2CCCCC2)C3=CC=CC=C3
InChI
InChIKey=LBKCCRHBZAWYOP-HUVSLODASA-N
InChI=1S/C20H29NO3.ClH/c1-21-14-8-13-18(15-21)24-19(22)20(23,16-9-4-2-5-10-16)17-11-6-3-7-12-17;/h2,4-5,9-10,17-18,23H,3,6-8,11-15H2,1H3;1H/t18-,20?;/m1./s1
| Molecular Formula | C20H29NO3 |
| Molecular Weight | 331.4492 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Propenzolate is a pyridine derivative patented by National Research Development Corp. as an anticholinergic agent. Propenzolate is effective antidotes to the cholinesterase-inhibiting action of various organophosphorus compounds. In clinical trials, Propenzolate has an activity that decreases to some extent the secretion of hydrochloric acid and the volume of gastric juice. Adverse effects, including nausea, vomiting, weakness, and drowsiness, as well as xerostomia and cycloplegia, are observed in a high percentage of patients receiving 0.5 to 1.0 mg. every 12 hours.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13885723
0.5 to 1.0 mg. every 12 hours.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:33:35 GMT 2025
by
admin
on
Mon Mar 31 19:33:35 GMT 2025
|
| Record UNII |
YCZ9J99C72
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000055021
Created by
admin on Mon Mar 31 19:33:35 GMT 2025 , Edited by admin on Mon Mar 31 19:33:35 GMT 2025
|
PRIMARY | |||
|
m438
Created by
admin on Mon Mar 31 19:33:35 GMT 2025 , Edited by admin on Mon Mar 31 19:33:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
YCZ9J99C72
Created by
admin on Mon Mar 31 19:33:35 GMT 2025 , Edited by admin on Mon Mar 31 19:33:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL2111025
Created by
admin on Mon Mar 31 19:33:35 GMT 2025 , Edited by admin on Mon Mar 31 19:33:35 GMT 2025
|
PRIMARY | |||
|
C170359
Created by
admin on Mon Mar 31 19:33:35 GMT 2025 , Edited by admin on Mon Mar 31 19:33:35 GMT 2025
|
PRIMARY | |||
|
DTXSID70931291
Created by
admin on Mon Mar 31 19:33:35 GMT 2025 , Edited by admin on Mon Mar 31 19:33:35 GMT 2025
|
PRIMARY | |||
|
118984356
Created by
admin on Mon Mar 31 19:33:35 GMT 2025 , Edited by admin on Mon Mar 31 19:33:35 GMT 2025
|
PRIMARY | |||
|
1420-03-7
Created by
admin on Mon Mar 31 19:33:35 GMT 2025 , Edited by admin on Mon Mar 31 19:33:35 GMT 2025
|
PRIMARY |